News | May 05, 2026
Silent cough, deadly risk: Doctors warn of hidden asthma surge amid rising pollution
Marking World Asthma Day 2026, doctors sounded the alarm over a steady surge in respiratory illnesses
Marking World Asthma Day 2026, doctors sounded the alarm over a steady surge in respiratory illnesses
The trials -- ELOWEN-1 and ELOWEN-2 -- are designed to evaluate the drug in people living with lupus who experience active skin manifestations
With big pharma leaning on external pipelines, the company sees opportunity in de-risked, high-impact assets with clear clinical endpoints
The submission is backed by positive results from the Phase 3 AFFIRM study
New formulation by Greenspace Herbs to target improved efficacy and lower dosage in curcumin supplements
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
At launch of updated pediatric gastroenterology textbook, Union Minister says technology must strengthen not substitute core medical learning
The results were consistent across both the 10 mg and 40 mg treatment arms
As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
